CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $53,762,000 | +4.7% | 1,590,606 | -27.5% | 0.00% | 0.0% |
| Q1 2021 | $51,327,000 | +7.5% | 2,194,414 | +32.4% | 0.00% | 0.0% |
| Q4 2020 | $47,730,000 | +8.7% | 1,657,307 | -23.5% | 0.00% | 0.0% |
| Q3 2020 | $43,900,000 | +5.9% | 2,166,813 | +57.1% | 0.00% | 0.0% |
| Q2 2020 | $41,459,000 | +275.1% | 1,379,671 | +292.3% | 0.00% | +200.0% |
| Q1 2020 | $11,052,000 | -14.5% | 351,644 | +28.2% | 0.00% | 0.0% |
| Q4 2019 | $12,920,000 | +690.2% | 274,244 | +8.4% | 0.00% | – |
| Q3 2019 | $1,635,000 | -47.5% | 253,030 | -0.2% | 0.00% | – |
| Q2 2019 | $3,112,000 | +29.0% | 253,439 | +42.3% | 0.00% | – |
| Q1 2019 | $2,413,000 | +3448.5% | 178,050 | +953.9% | 0.00% | – |
| Q4 2018 | $68,000 | – | 16,894 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $37,259,000 | 42.17% |
| Svennilson Peter | 4,677,939 | $57,446,000 | 16.42% |
| VHCP Management II, LLC | 726,677 | $8,924,000 | 2.81% |
| Casdin Capital, LLC | 1,523,960 | $18,714,229,000 | 1.75% |
| P.A.W. CAPITAL CORP | 120,000 | $1,474,000 | 1.59% |
| Cormorant Asset Management, LP | 1,271,685 | $15,616,000 | 0.90% |
| VHCP Management III, LLC | 66,667 | $819,000 | 0.38% |
| Orbimed Advisors | 835,842 | $10,264,000 | 0.16% |
| Hillhouse Capital Management | 317,921 | $3,904,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 183,600 | $2,255,000 | 0.08% |